Kristin Gurtner

881 total citations
16 papers, 595 citations indexed

About

Kristin Gurtner is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kristin Gurtner has authored 16 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kristin Gurtner's work include Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Kristin Gurtner is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Kristin Gurtner collaborates with scholars based in Germany, United States and Netherlands. Kristin Gurtner's co-authors include Michaël Baumann, Mechthild Krause, Yvonne Deuse, Veit Sandfort, Iris Eke, Anna Shevchenko, Nils Cordes, Stephanie Hehlgans, Ala Yaromina and Daniel Zips and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Kristin Gurtner

14 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristin Gurtner Germany 11 266 256 188 165 98 16 595
J. Baselga Spain 10 399 1.5× 312 1.2× 139 0.7× 188 1.1× 93 0.9× 25 649
Heike Zieher Germany 4 116 0.4× 270 1.1× 128 0.7× 141 0.9× 81 0.8× 6 496
Amy L. Lark United States 10 205 0.8× 326 1.3× 177 0.9× 179 1.1× 262 2.7× 13 639
Yoshiatsu Sagara Japan 14 484 1.8× 246 1.0× 101 0.5× 337 2.0× 28 0.3× 26 804
G. Gruber Switzerland 6 129 0.5× 370 1.4× 164 0.9× 413 2.5× 42 0.4× 9 649
Heidi Bissig Switzerland 8 386 1.5× 477 1.9× 165 0.9× 188 1.1× 28 0.3× 8 824
Takashi Ishigami Japan 13 124 0.5× 319 1.2× 76 0.4× 111 0.7× 24 0.2× 24 525
David J. Konieczkowski United States 8 257 1.0× 523 2.0× 112 0.6× 117 0.7× 25 0.3× 39 779
Natalia Bogdanova Germany 20 355 1.3× 613 2.4× 97 0.5× 332 2.0× 36 0.4× 51 1.1k
Zsuzsa Rákosy Hungary 15 259 1.0× 277 1.1× 44 0.2× 137 0.8× 28 0.3× 23 511

Countries citing papers authored by Kristin Gurtner

Since Specialization
Citations

This map shows the geographic impact of Kristin Gurtner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristin Gurtner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristin Gurtner more than expected).

Fields of papers citing papers by Kristin Gurtner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristin Gurtner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristin Gurtner. The network helps show where Kristin Gurtner may publish in the future.

Co-authorship network of co-authors of Kristin Gurtner

This figure shows the co-authorship network connecting the top 25 collaborators of Kristin Gurtner. A scholar is included among the top collaborators of Kristin Gurtner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristin Gurtner. Kristin Gurtner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Fleischhack, Gudrun, Julia Hauer, Gabriele Hahn, et al.. (2022). MEDB-34. A very rare case: medulloblastoma relapse with bone marrow infiltration in a toddler. Neuro-Oncology. 24(Supplement_1). i112–i112.
2.
Löck, Steffen, Kristin Gurtner, Ala Yaromina, et al.. (2021). Value of functional in-vivo endpoints in preclinical radiation research. Radiotherapy and Oncology. 158. 155–161. 5 indexed citations
3.
Gurtner, Kristin, Lydia Koi, Cyril H. Benes, et al.. (2019). Radioresistance of KRAS/TP53‐mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo. International Journal of Cancer. 147(2). 472–477. 39 indexed citations
4.
Thorwarth, Anne, Gabriele Hahn, Kristin Gurtner, et al.. (2019). Molecular Genetics in Brain Tumors – Case Report of a 7-year-old Girl with Recurrent Glioblastoma. Neuropediatrics.
5.
Han, Jing, Lynnette Marcar, Joshua C. Black, et al.. (2017). Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin–EGFR Pathway. Cancer Research. 77(8). 2018–2028. 77 indexed citations
6.
Koi, Lydia, Steffen Löck, Annett Linge, et al.. (2017). EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models. Radiotherapy and Oncology. 124(3). 496–503. 14 indexed citations
7.
Kriegs, Malte, Kristin Gurtner, I. Brammer, et al.. (2015). Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest. Radiotherapy and Oncology. 115(1). 120–127. 44 indexed citations
8.
Gurtner, Kristin, et al.. (2014). Effect of combined irradiation and EGFR/Erb-B inhibition with BIBW 2992 on proliferation and tumour cure in cell lines and xenografts. Radiation Oncology. 9(1). 261–261. 6 indexed citations
9.
10.
Koi, Lydia, Kerstin Brüchner, Kristin Gurtner, et al.. (2013). Hypoxia-Inducible Factor Pathway Inhibition Resolves Tumor Hypoxia and Improves Local Tumor Control After Single-Dose Irradiation. International Journal of Radiation Oncology*Biology*Physics. 88(1). 159–166. 29 indexed citations
11.
Eke, Iris, Yvonne Deuse, Stephanie Hehlgans, et al.. (2012). β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy. Journal of Clinical Investigation. 122(4). 1529–1540. 192 indexed citations
12.
Gurtner, Kristin, Yvonne Deuse, Rebecca Bütof, et al.. (2011). Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression. Radiotherapy and Oncology. 99(3). 323–330. 60 indexed citations
13.
Gurtner, Kristin, Franziska Hessel, Wolfgang Eicheler, et al.. (2011). Combined treatment of the immunoconjugate bivatuzumab mertansine and fractionated irradiation improves local tumour control in vivo. Radiotherapy and Oncology. 102(3). 444–449. 23 indexed citations
14.
Krause, Mechthild, Kristin Gurtner, Yvonne Deuse, & Michaël Baumann. (2009). Heterogeneity of tumour response to combined radiotherapy and EGFR inhibitors: Differences between antibodies and TK inhibitors. International Journal of Radiation Biology. 85(11). 943–954. 32 indexed citations
15.
Krause, Mechthild, Kristin Gurtner, Yvonne Deuse, Wolfgang Eicheler, & Michaël Baumann. (2009). 2006 Local tumour control after simultaneous fractionated irradiation and EGFR-blockade by monoclonal antibodies (Cetuximab) versus tyrosine kinase inhibitors (Erlotinib) in different head and neck squamous cell carcinoma (HNSCC) models. European Journal of Cancer Supplements. 7(2). 153–153. 1 indexed citations
16.
Zips, Daniel, Mechthild Krause, Ala Yaromina, et al.. (2008). Epidermal growth factor receptor inhibitors for radiotherapy: biological rationale and preclinical results. Journal of Pharmacy and Pharmacology. 60(8). 1019–1028. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Baselga Breakdown of academic impact, for papers by Heike Zieher Breakdown of academic impact, for papers by Amy L. Lark Breakdown of academic impact, for papers by Yoshiatsu Sagara Breakdown of academic impact, for papers by G. Gruber Breakdown of academic impact, for papers by Heidi Bissig Breakdown of academic impact, for papers by Takashi Ishigami Breakdown of academic impact, for papers by David J. Konieczkowski Breakdown of academic impact, for papers by Natalia Bogdanova Breakdown of academic impact, for papers by Zsuzsa Rákosy
Rankless by CCL
2026